Ashish Soman
Corporate Officer/Principal bei The Royal College of Physicians
Profil
Ashish Soman is a Member of The Royal College of Physicians.
He previously worked as the Country Medical Director at AstraZeneca Pty Ltd.
from 2009 to 2014 and as the Chief Medical Officer at OncoSil Medical Ltd.
from 2015 to 2019.
He completed his undergraduate degree at the University of London.
Currently, he holds a position at The Royal College of Physicians.
Aktive Positionen von Ashish Soman
| Unternehmen | Position | Beginn |
|---|---|---|
| The Royal College of Physicians | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ashish Soman
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOSIL MEDICAL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 20.09.2019 |
AstraZeneca Pty Ltd.
 AstraZeneca Pty Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca Pty Ltd. engages in the research, development, manufacture and supply of medicines and healthcare solutions. It also provides healthcare solutions designed to fight diseases in seven therapeutic areas including cardiovascular, neuroscience, gastrointestinal, infection, oncology and respiratory products. The company was founded in 1957 and is headquartered in Macquarie Park, Australia. | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Ashish Soman
| University of London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOSIL MEDICAL LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AstraZeneca Pty Ltd.
AstraZeneca Pty Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca Pty Ltd. engages in the research, development, manufacture and supply of medicines and healthcare solutions. It also provides healthcare solutions designed to fight diseases in seven therapeutic areas including cardiovascular, neuroscience, gastrointestinal, infection, oncology and respiratory products. The company was founded in 1957 and is headquartered in Macquarie Park, Australia. | Commercial Services |
